SLNCF — Silence Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Silence Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	10-K	10-K
Standards:	IFRS	IFRS	IFRS	USG	USG
Status:	fx Final	fx Final	fx Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	51.2	99.5	86.1	68.8	147
Net Total Accounts Receivable
Net Total Receivables	45.8	11.5	21	24	26.9
Prepaid Expenses
Total Other Current Assets
Total Current Assets	104	117	117	103	187
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.54	2.63	2.66	2.31	1.98
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	118	130	130	119	203
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	35	20.5	26.2	22.3	16.8
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	105	119	103	97.5	68.6
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	12.4	11.5	26.7	22	134
Total Liabilities & Shareholders' Equity	118	130	130	119	203
Total Common Shares Outstanding